NASDAQ Biotechnology Index
The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals.
Criteria
In order to remain included within the index, the components must meet the following criteria:
- The security U.S. listing must be exclusively on the NASDAQ National Market (unless the security was dually listed on another U.S. market prior to January 1, 2004 and has continuously maintained such listing).
- The issuer of the security must be classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals.
- The security may not be issued by an issuer currently in bankruptcy proceedings.
- The security must have a market capitalization of at least $200 million.
- The security must have an average daily trading volume of at least 100,000 shares.
- The issuer of the security may not have entered into a definitive agreement or other arrangement which would likely result in the security no longer being Index.
- The issuer of the security may not have annual financial statements with an audit opinion that is currently withdrawn.
- The issuer of the security must have "seasoned" on NASDAQ or another recognized market for at least 6 months; in the case of spin-offs, the operating history of the spin-off will be considered.
Components
This list of companies is current as of 10 June 2016.
- Avalanche Biotechnologies Inc. NASDAQ: AAVL
- ACADIA Pharmaceuticals Inc. NASDAQ: ACAD
- Achillion Pharmaceuticals Inc. NASDAQ: ACHN
- Acorda Therapeutics Inc. NASDAQ: ACOR
- Alcobra Inc. NASDAQ: ADHD
- Adamas Pharmaceuticals Inc. NASDAQ: ADMS
- Aduro BioTech Inc. NASDAQ: ADRO
- Aegerion Pharmaceuticals NASDAQ: AEGR
- Aerie Pharmaceuticals Inc. NASDAQ: AERI
- Affymetrix Inc. NASDAQ: AFFX
- Affimed Inc. NASDAQ: AFMD
- Agios Pharmaceuticals Inc. NASDAQ: AGIO
- Applied Genetic Technologies Corporation NASDAQ: AGTC
- Akebia Therapeutics Inc. NASDAQ: AKBA
- Akorn Inc. NASDAQ: AKRX
- Alder Biopharmaceuticals Inc. NASDAQ: ALDR
- Alkermes Inc. NASDAQ: ALKS
- Alnylam Pharmaceuticals Inc. NASDAQ: ALNY
- Alexion Pharmaceuticals Inc. NASDAQ: ALXN
- AMAG Pharmaceuticals Inc. NASDAQ: AMAG
- Amgen Inc. NASDAQ: AMGN
- Amphastar Pharmaceuticals Inc. NASDAQ: AMPH
- Albany Molecular Research Inc. NASDAQ: AMRI
- Amarin Corporation Inc. NASDAQ: AMRN
- Anacor Pharmaceuticals, Inc. NASDAQ: ANAC
- ANI Pharmaceuticals Inc. NASDAQ: ANIP
- Anthera Pharmaceuticals Inc. NASDAQ: ANTH
- Aquinox Pharmaceuticals Inc. NASDAQ: AQXP
- Ardelyx. NASDAQ: ARDX
- Ariad Pharmaceuticals Inc. NASDAQ: ARIA
- Arena Pharmaceuticals Inc. NASDAQ: AMNA
- Array BioPharma Inc. NASDAQ: ARRY
- Arrowhead Research Inc. NASDAQ: ATWR
- Atara Biotherapeutics Inc. NASDAQ: ATRA
- BioCryst Pharmaceuticals Inc. NASDAQ: BCRX
- Biogen Inc. NASDAQ: BIIB
- Bellicum Pharmaceuticals Inc. NASDAQ: BLCM
- Bluebird bio Inc. NASDAQ: BLUE
- BioMarin Pharmaceutical Inc. NASDAQ: BMRN
- Blueprint Medicines Inc. NASDAQ: BPMC
- Cara Therapeutics Inc. NASDAQ: CARA
- Cascadian Therapeutics Inc. NASDAQ: CASC
- China Biologic Products Inc. NASDAQ: CBPO
- ChemoCentryx Inc. NASDAQ: CCXI
- Celgene Corporation NASDAQ: CELG
- Cempra Inc. NASDAQ: CEMP
- Celgene Corporation NASDAQ: CELG
- Cerus Inc. NASDAQ: CERS
- Compugen NASDAQ: CGEN
- Chiasma Inc. NASDAQ: CHMA
- Coherus Biosciencess Inc. NASDAQ: CHRS
- Celldex Therapeutics Inc. NASDAQ: CLDX
- Clovis Oncology Inc. NASDAQ: CLVS
- Chimerix Inc. NASDAQ: CMRX
- Concert Pharmaceuticals NASDAQ: CNCE
- Collegium Pharmaceutica Inc. NASDAQ: COLL
- Curis NASDAQ: CRIS
- Concordia Healthcare Inc. NASDAQ: CXRX[1]
- DBV Technologies Inc. NASDAQ: DBVT
- Depomed Inc. NASDAQ: DEPO
- Dermira NASDAQ: DERM
- ProNAi Therapeutics NASDAQ: DNAI
- Dicerna Pharmaceuticals NASDAQ: DRNA
- DURECT Inc. NASDAQ: DRRX[2]
- Endocyte Inc. NASDAQ: ECYT
- Egalet NASDAQ: EGLT
- Eagle Pharmaceuticals Inc. NASDAQ: EGRX
- Endo International NASDAQ: ENDO
- Enanta Pharmaceuticals Inc. NASDAQ: ENTA
- Epizyme Inc. NASDAQ: EPZM
- Esperion Therapeutics NASDAQ: ESPR
- Exelixis Inc. NASDAQ: EXEL[3]
- FibroGen Inc. NASDAQ: FGEN
- Flex Pharma Inc. NASDAQ: FLKS
- Flamel Technologies NASDAQ: FLML
- Flexion Therapeutics NASDAQ: FLXN
- Foundation Medicine NASDAQ: FMI
- Amicus Therapeutics NASDAQ: FOLD
- Foamix Pharmaceuticals NASDAQ: FOMX
- Five Prime Therapeutics NASDAQ: FPRX[4]
- Geron Corporation NASDAQ: GERN
- Genomic Health Inc. NASDAQ: GHDX
- Gilead Sciences Inc. NASDAQ: GILD
- Grifols Inc. NASDAQ: GPFS
- Grifols, S.A. NASDAQ: GRFS
- GW Pharmaceuticals NASDAQ: GWPH[5]
- Halozyme Therapeutics Inc. NASDAQ: HALO
- Horizon Pharma Inc. NASDAQ: HZNP[6]
- Intercept Pharmaceuticals Inc. NASDAQ: ICPT
- Illumina Inc. NASDAQ: ILMN
- Immune Design Inc. NASDAQ: IMDZ
- ImmunoGen Inc. NASDAQ: IMGN
- Immunomedics Inc. NASDAQ: IMMU
- INC Research Holdings Corporation NASDAQ: INCR
- Incyte Corporation NASDAQ: INCY
- Infinity Pharmaceuticals Inc. NASDAQ: INFI
- Inovio Pharmaceuticals Inc. NASDAQ: INO
- Insmed Incorporated Inc. NASDAQ: INSM
- INSYS Therapeutics Inc. NASDAQ: INSY
- Ionis Pharmaceuticals Inc. NASDAQ: IONS
- Impax Laboratories Inc. NASDAQ: IPXL
- Ironwood Pharmaceuticals Inc. NASDAQ: IRWD
- Ionis Pharmaceuticals Inc. NASDAQ: IONS
- Inotek Pharmaceuticals Inc. NASDAQ: ITEK[7]
- Jazz Pharmaceuticals Inc. NASDAQ: JAZZ
- Juno Therapeutics Inc. NASDAQ: JUNO[8]
- Kite Pharma Inc. NASDAQ: KITE
- KemPharm Inc. NASDAQ: KMPH
- Karyopharm Therapeutics Inc. NASDAQ: KPTI[9]
- Lion Biotechnologies Inc. NASDAQ: LBIO
- Ligand Pharmaceuticals Incorpor NASDAQ: LGND
- aTyr Pharma NASDAQ: LIFE
- Luminex Corporation NASDAQ: LMNX
- Lexicon Pharmaceuticals Inc. NASDAQ: LXRX[10]
- Merrimack Pharmaceuticals Inc. NASDAQ: MACK
- Seres Therapeutics, Inc. NASDAQ: MCRB
- The Medicines Company NASDAQ: MDCO
- Medivation Inc. NASDAQ: MDVN
- MacroGenics, Inc. NASDAQ: MGNX
- MannKind Corporation NASDAQ: MNKD
- Momenta Pharmaceuticals Inc. NASDAQ: MNTA
- Myriad Genetics Inc. NASDAQ: MYGN
- Mylan Inc. NASDAQ: MYL[11]
- Neurocrine Biosciences Inc. NASDAQ: NBIX
- NeuroDerm Inc. NASDAQ: NDRM
- NantKwest NASDAQ: NK
- Nektar Therapeutics NASDAQ: NKTR
- NewLink Genetics Inc. NASDAQ: NLNK
- NanoString Technologies Inc. NASDAQ: NSTG
- Novavax, Inc. NASDAQ: NVAX[12]
- Ocular Therapeutix Inc.NASDAQ: OCUL
- OncoMed Pharmaceuticals, Inc.NASDAQ: OMED
- Omeros CorporationNASDAQ: OMER
- Spark Therapeutics, Inc.NASDAQ: ONCE
- Ophthotech CorporationNASDAQ: OPTH
- Orexigen Therapeutics, IncNASDAQ: OREX
- Osiris Therapeutics, Inc.NASDAQ: OSIR
- Otonomy, Inc.NASDAQ: OTIC
- OvaScience, Inc.NASDAQ: OVAS
- Pacific Biosciences of California Inc. NASDAQ: PACB
- Pacira Pharmaceuticals Inc. NASDAQ: PCRX
- PDL BioPharma Inc. NASDAQ: PDLI
- Aratana Therapeutics Inc. NASDAQ: PETX
- Progenics Pharmaceuticals Inc. NASDAQ: PGNX
- Prothena NASDAQ: PRTA
- PTC Therapeutics NASDAQ: PTCT
- Portola Pharmaceuticals[14]
- Qiagen N.V. NASDAQ: QGEN
- uniQure N.V. NASDAQ: QURE[15]
- Ultragenyx Pharmaceutical Inc. NASDAQ: RARE
- Radius Health Inc. NASDAQ: RDUS
- Regeneron Pharmaceuticals Inc. NASDAQ: REGN
- Repligen Inc. NASDAQ: RGEN
- Regulus Therapeutics Inc. NASDAQ: RGLS
- Rigel Pharmaceuticals Inc. NASDAQ: RIGL
- Relypsa Inc. NASDAQ: RLYP
- Raptor Pharmaceuticals Inc. NASDAQ: RPTP
- Retrophin Inc. NASDAQ: RTRX
- Revance Therapeutics Inc. NASDAQ: RVNC[16]
- Sage Therapeutics Inc. NASDAQ: SAGE
- SciClone Pharmaceuticals Inc. NASDAQ: SCLN
- Sucampo Pharmaceuticals Inc. NASDAQ: SCMP
- Seattle Genetics Inc. NASDAQ: SGEN
- Sangamo Biosciences Inc. NASDAQ: SGMO
- Sagent Pharmaceuticals Inc. NASDAQ: SGNT
- Synergy Pharmaceuticals Inc. NASDAQ: SGYP
- Shire plc NASDAQ: SHPGY
- Spectrum Pharmaceuticals Inc. NASDAQ: SPPI
- Sequenom Inc. NASDAQ: SQNM
- Sarepta Therapeutics Ltd. NASDAQ: SRPT
- Supernus Pharmaceuticals Inc. NASDAQ: SUPN[17]
- Theravance Biopharma Inc.NASDAQ: TBPH
- Bio-Techne Corporation NASDAQ: TECH
- Theravance Inc. NASDAQ: THRX
- Tokai PharmaceuticalsInc NASDAQ: TKAI
- Teligent, Inc. NASDAQ: TLGT
- Trevena Inc NASDAQ: TRVN
- Tesaro Inc. NASDAQ: TSRO
- Tetraphase Pharmaceuticals Inc. NASDAQ: TTPH[18]
- United Therapeutics Corporation NASDAQ: UTHR[19]
- Vanda Pharmaceuticals Inc. NASDAQ: VNDA
- Vertex Pharmaceuticals Incorporated NASDAQ: VRTX
- Versartis Inc. NASDAQ: VSAR
- Vital Therapies Inc. NASDAQ: VTL
- Vitae Pharmaceuticals Incorporated NASDAQ: VTAE[20]
- XBiotech Inc. NASDAQ: XBIT
- Acceleron Pharma Inc. NASDAQ: XLRN
- Xencor Inc. NASDAQ: XNCR
- XenoPort Inc. NASDAQ: XNPT[21]
- Zafgen Inc. NASDAQ: ZFGN
- Zogenix Inc. NASDAQ: ZGNX
November 2011 changes
In November 2011 the following were added:
- Amarin Corporation plc NASDAQ: AMRN
- BioSante Pharmaceuticals Inc NASDAQ: BPAX
- Endocyte Inc NASDAQ: ECYT
- Grifols S.A. NASDAQ: GRFS
- Oncothyreon Inc NASDAQ: ONTY
- SciClone Pharmaceuticals Inc NASDAQ: SCLN
- Sagent Pharmaceuticals Inc NASDAQ: SGNT
The following were removed from the index:
- Alexza Pharmaceuticals Inc NASDAQ: ALXA
- Albany Molecular Research Inc NASDAQ: AMRI
- BioMimetic Therapeutics Inc NASDAQ: BMTI
- Cytokinetics Incorporated NASDAQ: CYTK
- Flamel Technologies S.A. NASDAQ: FLML
- Nabi Biopharmaceuticals NASDAQ: NABI
- Orexigen Therapeutics Inc NASDAQ: OREX
- POZEN Inc NASDAQ: POZN
- StemCells Inc NASDAQ: STEM
- Zalicus Inc NASDAQ: ZLCS
Investing
This index is tracked by an exchange-traded fund, iShares Nasdaq Biotechnology (NASDAQ: IBB).
References
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "^NBI Components". finance.yahoo.com. Retrieved 4 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NBI Components". finance.yahoo.com. Retrieved 3 January 2016.
- ↑ "NASDAQ Biotechnology Index Components". finance.yahoo.com.
- ↑ "NBI Components". finance.yahoo.com.
External links
This article is issued from Wikipedia - version of the 6/10/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.